Bolt Biotherapeutics SG&A Expense (TTM) Insights

Bolt Biotherapeutics Inc (BOLT)

0.6203 +0.04 (+6.31%) USD | NASDAQ | Sep 27, 16:00

0.6588 +0.04 (+6.21%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
June 30, 2024	22.00M
March 31, 2024	22.75M
December 31, 2023	22.53M
September 30, 2023	22.60M
June 30, 2023	22.33M
March 31, 2023	22.24M
December 31, 2022	22.93M
September 30, 2022	22.42M

Date	Value
June 30, 2022	21.88M
March 31, 2022	20.40M
December 31, 2021	18.39M
September 30, 2021	15.35M
June 30, 2021	13.28M
March 31, 2021	11.23M
December 31, 2020	9.056M
September 30, 2020	9.135M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

9.056M

Minimum

Dec 2020

22.93M

Maximum

Dec 2022

18.66M

Average

21.94M

Median

SG&A Expense (TTM) Benchmarks